Details for 2019204003
Up to date per 27.05.2026
Actions
Details for 2019204003
Granted/Registered
European Patent
03.06.2020 A
24.01.2024 B1
11.02.2013
US
201361763395 P
11.03.2013
US
201361776283 P
A61M 5/20 20060101AFI20200421BHEP
Owner
Antares Pharma, Inc.100 Charles Ewing Blvd., Suite 300 Princeton South Corporate Center Ewing, NJ 08628US
Representative
Representative
Kliment & Henhapel Patentanwälte OGGonzagagasse 151010 WIENAT
Inventor
TRAVANTY, Michael4202 Portland Avenue S. Minneapolis, MN 55407US
Information about Fees